Ronaldo Delmonte Piovezan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Ronaldo Delmonte Piovezan has a total of 71 co-authors. Here are the top co-authors by number of shared publications:
Sergio Tufik
Department of Psychobiology, Universidade Federal de São Paulo, São Paulo, Brazil
8 shared publicationsDalva Poyares
Department of Psychobiology, Universidade Federal de São Paulo, São Paulo, Brazil
7 shared publications- Dalva Poyares
Departamento de Psicobiologia, Universidade Federal de São Paulo, São Paulo, Brazil
6 shared publications - Sergio Tufik
Departamento de Psicobiologia, Universidade Federal de São Paulo, São Paulo, Brazil
4 shared publications Camila Hirotsu
Department of Psychobiology, Universidade Federal de São Paulo, São Paulo, Brazil
2 shared publications- Conrado Regis Borges
Faculdade Sírio-Libanês, São Paulo SP, Brazil
2 shared publications
Latest Publications
- Open Access
- 12 May 2026
- Published by Georg Thieme Verlag KG in Arquivos de Neuro-Psiquiatria
- Vol. 84 (07) , 001-002
From science to sleep: the promise of dual orexin receptor antagonists
- 12 May 2026
- Published by Georg Thieme Verlag KG in Arquivos de Neuro-Psiquiatria
- Vol. 84 (07) , 001-002
Open AccessFrom science to sleep: the promise of dual orexin receptor antagonists
- 13 April 2023
- Published by Elsevier in Journal of the American Medical Directors Association
- Vol. 24 (10) , 1458-1464.e4
Daytime Sleepiness Predicts Mortality in Nursing Home Residents: Findings from the Frailty in Residential Aged Care Sector Over Time (FIRST) Study
- 13 April 2023
- Published by Elsevier in Journal of the American Medical Directors Association
- Vol. 24 (10) , 1458-1464.e4
Daytime Sleepiness Predicts Mortality in Nursing Home Residents: Findings from the Frailty in Residential Aged Care Sector Over Time (FIRST) Study
- Open Access
- 6 December 2022
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 19 (23) , 16322
Resistance Training Improves Sleep and Anti-Inflammatory Parameters in Sarcopenic Older Adults: A Randomized Controlled Trial
Sleep and exercise have an important role in the development of several inflammation-related diseases, including sarcopenia. Objective: To investigate the effects of 12 weeks of resistance exercise training on sleep and inflammatory status in sarcopenic patients. Methods: A randomized controlled trial comparing resistance exercise training (RET) with a control (CTL) was conducted. Outcomes were obtained by physical tests, polysomnography, questionnaires, isokinetic/isometric dynamometry tests, and biochemical analysis. Results: Time to sleep onset (sleep latency) was reduced in the RET group compared to the CTL group (16.09 ± 15.21 vs. 29.98 ± 16.09 min; p = 0.04) after the intervention. The percentage of slow-wave sleep (N3 sleep) was increased in the RET group (0.70%, CI: 7.27–16.16 vs. −4.90%, CI: 7.06–16.70; p = 0.04) in an intention to treat analysis. Apnea/hour was reduced in the RET group (16.82 ± 14.11 vs. 7.37 ± 7.55; p = 0.001) and subjective sleep quality was improved compared to the CTL (−1.50; CI: 2.76–6.14 vs. 0.00; CI: 1.67–3.84 p = 0.02) in an intention-to-treat analysis. Levels of interleukin-10 (IL-10) (2.13 ± 0.80 vs. 2.51 ± 0.99; p < 0.03) and interleukin-1 receptor antagonist (IL-1ra) (0.99 ± 0.10 vs. 0.99 ± 0.10 ng/mL; p < 0.04; delta variation) were increased in the RET group. Conclusions: RET improves sleep parameters linked to muscle performance, possibly due to an increase in anti-inflammatory markers in older sarcopenic patients.
- 6 December 2022
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 19 (23) , 16322
Open AccessResistance Training Improves Sleep and Anti-Inflammatory Parameters in Sarcopenic Older Adults: A Randomized Controlled Trial
Sleep and exercise have an important role in the development of several inflammation-related diseases, including sarcopenia. Objective: To investigate the effects of 12 weeks of resistance exercise training on sleep and inflammatory status in sarcopenic patients. Methods: A randomized controlled trial comparing resistance exercise training (RET) with a control (CTL) was conducted. Outcomes were obtained by physical tests, polysomnography, questionnaires, isokinetic/isometric dynamometry tests, and biochemical analysis. Results: Time to sleep onset (sleep latency) was reduced in the RET group compared to the CTL group (16.09 ± 15.21 vs. 29.98 ± 16.09 min; p = 0.04) after the intervention. The percentage of slow-wave sleep (N3 sleep) was increased in the RET group (0.70%, CI: 7.27–16.16 vs. −4.90%, CI: 7.06–16.70; p = 0.04) in an intention to treat analysis. Apnea/hour was reduced in the RET group (16.82 ± 14.11 vs. 7.37 ± 7.55; p = 0.001) and subjective sleep quality was improved compared to the CTL (−1.50; CI: 2.76–6.14 vs. 0.00; CI: 1.67–3.84 p = 0.02) in an intention-to-treat analysis. Levels of interleukin-10 (IL-10) (2.13 ± 0.80 vs. 2.51 ± 0.99; p < 0.03) and interleukin-1 receptor antagonist (IL-1ra) (0.99 ± 0.10 vs. 0.99 ± 0.10 ng/mL; p < 0.04; delta variation) were increased in the RET group. Conclusions: RET improves sleep parameters linked to muscle performance, possibly due to an increase in anti-inflammatory markers in older sarcopenic patients.
- Open Access
- 1 October 2021
- Published by EDITORA SCIENTIFIC in Brazilian Journal of Psychiatry
- Vol. 43 (5) , 510-513
Subjective sleep parameters in prodromal Alzheimer’s disease: a case-control study
Objective: People with Alzheimer's disease (AD) dementia have impaired sleep. However, the characteristics of sleep in the early stages of AD are not well known, and studies with the aid of biomarkers are lacking. We assessed the subjective sleep characteristics of non-demented older adults and compared their amyloid profiles. Methods: We enrolled 30 participants aged >= 60 years, with no dementia or major clinical and psychiatric diseases. They underwent [C-11]PiB-PET-CT, neuropsychological evaluations, and completed two standardized sleep assessments (Pittsburgh Sleep Quality Inventory and Epworth Sleep Scale). Results: Comparative analysis of subjective sleep parameters across the two groups showed longer times in bed (p = 0.024) and reduced sleep efficiency (p = 0.05) in individuals with positive amyloid. No differences in other subjective sleep parameters were observed. We also found that people with multiple-domain mild cognitive impairment (MCI) had shorter self-reported total sleep times (p = 0.034) and worse overall sleep quality (p = 0.027) compared to those with single-domain MCI. Conclusions: Older adults testing positive for amyloid had a longer time in bed and lower sleep efficiency, regardless of cognitive status. In parallel, individuals with multiple-domain MCI reported shorter sleep duration and lower overall sleep quality.
- 1 October 2021
- Published by EDITORA SCIENTIFIC in Brazilian Journal of Psychiatry
- Vol. 43 (5) , 510-513
Open AccessSubjective sleep parameters in prodromal Alzheimer’s disease: a case-control study
Objective: People with Alzheimer's disease (AD) dementia have impaired sleep. However, the characteristics of sleep in the early stages of AD are not well known, and studies with the aid of biomarkers are lacking. We assessed the subjective sleep characteristics of non-demented older adults and compared their amyloid profiles. Methods: We enrolled 30 participants aged >= 60 years, with no dementia or major clinical and psychiatric diseases. They underwent [C-11]PiB-PET-CT, neuropsychological evaluations, and completed two standardized sleep assessments (Pittsburgh Sleep Quality Inventory and Epworth Sleep Scale). Results: Comparative analysis of subjective sleep parameters across the two groups showed longer times in bed (p = 0.024) and reduced sleep efficiency (p = 0.05) in individuals with positive amyloid. No differences in other subjective sleep parameters were observed. We also found that people with multiple-domain mild cognitive impairment (MCI) had shorter self-reported total sleep times (p = 0.034) and worse overall sleep quality (p = 0.027) compared to those with single-domain MCI. Conclusions: Older adults testing positive for amyloid had a longer time in bed and lower sleep efficiency, regardless of cognitive status. In parallel, individuals with multiple-domain MCI reported shorter sleep duration and lower overall sleep quality.
- 1 January 2021
- Published by Georg Thieme Verlag KG in Geriatrics Gerontology and Aging
- Vol. 15, 1-2
Hypnotics: evidence vs practice
- 1 January 2021
- Published by Georg Thieme Verlag KG in Geriatrics Gerontology and Aging
- Vol. 15, 1-2
Hypnotics: evidence vs practice
- Open Access
- 1 October 2020
- Published by FapUNIFESP (SciELO) in Arquivos de Neuro-Psiquiatria
- Vol. 78 (10) , 601-602
REM Behavior Disorder diagnostic challenges
For the clinician, the recommended stepwise approach to detect and confirm a suspected case of RBD can also become a prolonged endeavor. A detailed history of the abnormal behavior, its frequency, the severity of episodes, time of the night, and other neurological or psychiatric symptoms play an essential role in the diagnostic pathway of RBD. Furthermore, polysomnographic (PSG) criteria for the diagnosis is still advancing and expecting a consensus, as the American Academy of Sleep Medicine (AASM) considers over 50% of each 30-second epoch of REM without atonia to confirm the RBD diagnosis4, while the International Classification of Sleep Disorders - Third Edition (ICSD-3) establishes over 27% for the same parameter5. Video monitoring to document the abnormal behavior, as well as vocalizations, is highly recommended. Moreover4, PSG visual scoring is somehow subjective, and the occurrence of apnea events and arousals during REM sleep also impairs the proper electromyographic (EMG) analysis. Ultimately, RBD episodes may not occur nightly. Likely, a clear episode does not happen in a single PSG night.
- 1 October 2020
- Published by FapUNIFESP (SciELO) in Arquivos de Neuro-Psiquiatria
- Vol. 78 (10) , 601-602
Open AccessREM Behavior Disorder diagnostic challenges
For the clinician, the recommended stepwise approach to detect and confirm a suspected case of RBD can also become a prolonged endeavor. A detailed history of the abnormal behavior, its frequency, the severity of episodes, time of the night, and other neurological or psychiatric symptoms play an essential role in the diagnostic pathway of RBD. Furthermore, polysomnographic (PSG) criteria for the diagnosis is still advancing and expecting a consensus, as the American Academy of Sleep Medicine (AASM) considers over 50% of each 30-second epoch of REM without atonia to confirm the RBD diagnosis4, while the International Classification of Sleep Disorders - Third Edition (ICSD-3) establishes over 27% for the same parameter5. Video monitoring to document the abnormal behavior, as well as vocalizations, is highly recommended. Moreover4, PSG visual scoring is somehow subjective, and the occurrence of apnea events and arousals during REM sleep also impairs the proper electromyographic (EMG) analysis. Ultimately, RBD episodes may not occur nightly. Likely, a clear episode does not happen in a single PSG night.
- Open Access
- 19 May 2020
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 75 (2) , 581-593
Mortality Rates and Mortality Risk Factors in Older Adults with Dementia from Low- and Middle-Income Countries: The 10/66 Dementia Research Group Population-Based Cohort Study
Background: Dementia is the main cause of disability in older people living in low- and middle-income countries (LMIC). Monitoring mortality rates and mortality risk factors in people with dementia (PwD) may contribute to improving care provision. Ob
- 19 May 2020
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 75 (2) , 581-593
Open AccessMortality Rates and Mortality Risk Factors in Older Adults with Dementia from Low- and Middle-Income Countries: The 10/66 Dementia Research Group Population-Based Cohort Study
Background: Dementia is the main cause of disability in older people living in low- and middle-income countries (LMIC). Monitoring mortality rates and mortality risk factors in people with dementia (PwD) may contribute to improving care provision. Ob
- Open Access
- 1 November 2019
- Published by FapUNIFESP (SciELO) in Arquivos de Neuro-Psiquiatria
- Vol. 77 (11) , 815-824
Alzheimer's disease and sleep disturbances: a review
Alzheimer's disease (AD) is the most prevalent neurodegenerative disorder and is associated with sleep problems. Many previous studies have shown that sleep disorders are risk factors for AD. On the other hand, patients with mild cognitive impairment (MCI) and AD have shown an increased frequency of sleep disorders. This evidence implies an hypothesis of the existence of a bidirectional association between sleep and AD2.
- 1 November 2019
- Published by FapUNIFESP (SciELO) in Arquivos de Neuro-Psiquiatria
- Vol. 77 (11) , 815-824
Open AccessAlzheimer's disease and sleep disturbances: a review
Alzheimer's disease (AD) is the most prevalent neurodegenerative disorder and is associated with sleep problems. Many previous studies have shown that sleep disorders are risk factors for AD. On the other hand, patients with mild cognitive impairment (MCI) and AD have shown an increased frequency of sleep disorders. This evidence implies an hypothesis of the existence of a bidirectional association between sleep and AD2.
- Open Access
- 24 May 2019
- Published by Wiley in Journal of Cachexia, Sarcopenia and Muscle
- Vol. 10 (5) , 962-973
Associations between sleep conditions and body composition states: results of the EPISONO study
Background: Evidence suggests anthropometric indicators of obesity are associated with changes in sleep quality and quantity, and the presence of obstructive sleep apnoea (OSA). Investigations including diverse and objective evaluations of sleep and body composition are scarce. We aimed to evaluate the associations between indicators of sleep impairment and body composition states in a sample from a population‐based study.Methods: Participants of the first follow‐up of the EPISONO (São Paulo, Brazil) >50 years were cross‐sectionally evaluated. Sleep was assessed through questionnaires, actigraphy, and polysomnography. Body composition was evaluated by bioelectrical impedance analysis. Appendicular skeletal muscle mass adjusted for body mass index defined sarcopenia (men 40%). The overlap between both conditions defined sarcopenic obesity (SO). Final results were obtained by multinomial logistic regression analysis.Results: Three hundred fifty‐nine adults [mean (standard deviation) age, 61 (8.8) years; 212 (59.1%) female] were enrolled. Obesity was detected in 22.6% of the sample, sarcopenia in 5.6%, and SO in 16.2%. After controlling for covariates, OSA was associated with SO [odds ratio = 3.14, 95% confidence interval (CI) = 1.49–6.61]. Additionally, nocturnal hypoxaemia was associated with both obesity (adjusted odds ratio = 2.59, 95% CI = 1.49–4.49) and SO (odds ratio = 2.92, 95% CI = 1.39–6.13). Other indicators of poor sleep/sleep disorders were not associated with body composition states.Conclusions: Sarcopenic obesity but not obesity alone was associated with OSA. Both obesity and SO but not sarcopenia were associated with nocturnal hypoxaemia. The findings suggest a complex pathophysiologic relationship between adverse body composition states and OSA. Upcoming research on risk factors and therapeutic interventions for OSA should target synchronically the lean and adipose body tissues.
- 24 May 2019
- Published by Wiley in Journal of Cachexia, Sarcopenia and Muscle
- Vol. 10 (5) , 962-973
Open AccessAssociations between sleep conditions and body composition states: results of the EPISONO study
Background: Evidence suggests anthropometric indicators of obesity are associated with changes in sleep quality and quantity, and the presence of obstructive sleep apnoea (OSA). Investigations including diverse and objective evaluations of sleep and body composition are scarce. We aimed to evaluate the associations between indicators of sleep impairment and body composition states in a sample from a population‐based study.Methods: Participants of the first follow‐up of the EPISONO (São Paulo, Brazil) >50 years were cross‐sectionally evaluated. Sleep was assessed through questionnaires, actigraphy, and polysomnography. Body composition was evaluated by bioelectrical impedance analysis. Appendicular skeletal muscle mass adjusted for body mass index defined sarcopenia (men 40%). The overlap between both conditions defined sarcopenic obesity (SO). Final results were obtained by multinomial logistic regression analysis.Results: Three hundred fifty‐nine adults [mean (standard deviation) age, 61 (8.8) years; 212 (59.1%) female] were enrolled. Obesity was detected in 22.6% of the sample, sarcopenia in 5.6%, and SO in 16.2%. After controlling for covariates, OSA was associated with SO [odds ratio = 3.14, 95% confidence interval (CI) = 1.49–6.61]. Additionally, nocturnal hypoxaemia was associated with both obesity (adjusted odds ratio = 2.59, 95% CI = 1.49–4.49) and SO (odds ratio = 2.92, 95% CI = 1.39–6.13). Other indicators of poor sleep/sleep disorders were not associated with body composition states.Conclusions: Sarcopenic obesity but not obesity alone was associated with OSA. Both obesity and SO but not sarcopenia were associated with nocturnal hypoxaemia. The findings suggest a complex pathophysiologic relationship between adverse body composition states and OSA. Upcoming research on risk factors and therapeutic interventions for OSA should target synchronically the lean and adipose body tissues.
- Open Access
- 7 July 2017
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 12 (7) , e0180901
Obstructive sleep apnea and objective short sleep duration are independently associated with the risk of serum vitamin D deficiency
Studies demonstrate an association between vitamin D (25(OH)D) deficiency and sleep disturbances, such as obstructive sleep apnea (OSA) and short sleep duration. However, to date, no studies have concurrently and objectively evaluated the effect of these factors on 25(OH)D. To evaluate whether OSA and objective short sleep duration are independently associated with reduced 25(OH)D in an adult population sample. A cross-sectional study included 657 individuals from the city of Sao Paulo, Brazil, as part of the ERA project. Participants fulfilled questionnaires and underwent clinical evaluation, polysomnography and blood sample collection for 25(OH)D quantification. OSA was classified into three categories (mild, moderate and severe). The risk of 25(OH)D deficiency was considered as levels<30 ng/mL. Short sleep duration was defined as total sleep time<6 hours. The risk of 25(OH)D deficiency was observed in 59.5% of the sample, affecting more individuals of the female gender, obese, with African American ethnicity, and those that were smokers, sedentary and presented hypertension and diabetes. In the final logistic model adjusted for age, gender, ethnicity, obesity, smoking, hypertension, diabetes, sedentary lifestyle, seasonality and creatinine serum levels, both OSA and short sleep duration showed significant independent associations with the risk of 25(OH)D deficiency (moderate OSA: OR for 25(OH)D<30 = 2.21, 95% CI: 1.35–3.64, p<0.01; severe OSA: OR for 25(OH)D<30 = 1.78, 95% CI: 1.06–3.00, p = 0.03; short sleep duration: OR for 25(OH)D<30 = 1.61, 95% CI: 1.15–2.26, p = 0.01). After a subgroup analysis, similar results were observed only in participants ≥50 years. OSA and short sleep duration are independently associated with the risk of 25(OH)D deficiency in an adult population. Age-related changes in vitamin D metabolism and the frequency of sleep disorders may be involved in these associations. Future studies exploring whether 25(OH)D levels may modulate OSA and sleep curtailment-related outcomes are needed.
- 7 July 2017
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 12 (7) , e0180901
Open AccessObstructive sleep apnea and objective short sleep duration are independently associated with the risk of serum vitamin D deficiency
Studies demonstrate an association between vitamin D (25(OH)D) deficiency and sleep disturbances, such as obstructive sleep apnea (OSA) and short sleep duration. However, to date, no studies have concurrently and objectively evaluated the effect of these factors on 25(OH)D. To evaluate whether OSA and objective short sleep duration are independently associated with reduced 25(OH)D in an adult population sample. A cross-sectional study included 657 individuals from the city of Sao Paulo, Brazil, as part of the ERA project. Participants fulfilled questionnaires and underwent clinical evaluation, polysomnography and blood sample collection for 25(OH)D quantification. OSA was classified into three categories (mild, moderate and severe). The risk of 25(OH)D deficiency was considered as levels<30 ng/mL. Short sleep duration was defined as total sleep time<6 hours. The risk of 25(OH)D deficiency was observed in 59.5% of the sample, affecting more individuals of the female gender, obese, with African American ethnicity, and those that were smokers, sedentary and presented hypertension and diabetes. In the final logistic model adjusted for age, gender, ethnicity, obesity, smoking, hypertension, diabetes, sedentary lifestyle, seasonality and creatinine serum levels, both OSA and short sleep duration showed significant independent associations with the risk of 25(OH)D deficiency (moderate OSA: OR for 25(OH)D<30 = 2.21, 95% CI: 1.35–3.64, p<0.01; severe OSA: OR for 25(OH)D<30 = 1.78, 95% CI: 1.06–3.00, p = 0.03; short sleep duration: OR for 25(OH)D<30 = 1.61, 95% CI: 1.15–2.26, p = 0.01). After a subgroup analysis, similar results were observed only in participants ≥50 years. OSA and short sleep duration are independently associated with the risk of 25(OH)D deficiency in an adult population. Age-related changes in vitamin D metabolism and the frequency of sleep disorders may be involved in these associations. Future studies exploring whether 25(OH)D levels may modulate OSA and sleep curtailment-related outcomes are needed.